Trial Profile
Phase II, Multicenter Study of Decitabine (5-Aza-2'Deoxycytidine) in Chronic Myelogenous Leukemia Chronic Phase Refractory to Imatinib Mesylate (STI 571).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Decitabine (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Astex Pharmaceuticals
- 21 Sep 2006 New trial record.